177 related articles for article (PubMed ID: 27765905)
1. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
[TBL] [Abstract][Full Text] [Related]
2. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional adaptation of neuroblastoma cells to hypoxia.
Fredlund E; Ovenberger M; Borg K; Påhlman S
Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
Axelson H; Fredlund E; Ovenberger M; Landberg G; Påhlman S
Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
[TBL] [Abstract][Full Text] [Related]
5. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
6. HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.
Nilsson H; Jögi A; Beckman S; Harris AL; Poellinger L; Påhlman S
Exp Cell Res; 2005 Feb; 303(2):447-56. PubMed ID: 15652356
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.
Holmquist-Mengelbier L; Fredlund E; Löfstedt T; Noguera R; Navarro S; Nilsson H; Pietras A; Vallon-Christersson J; Borg A; Gradin K; Poellinger L; Påhlman S
Cancer Cell; 2006 Nov; 10(5):413-23. PubMed ID: 17097563
[TBL] [Abstract][Full Text] [Related]
8. Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.
Hsu CL; Chang HY; Chang JY; Hsu WM; Huang HC; Juan HF
Oncotarget; 2016 Jun; 7(24):36293-36310. PubMed ID: 27167114
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced dedifferentiation in neuroblastoma cells.
Jögi A; Øra I; Nilsson H; Poellinger L; Axelson H; Påhlman S
Cancer Lett; 2003 Jul; 197(1-2):145-50. PubMed ID: 12880974
[TBL] [Abstract][Full Text] [Related]
11. An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma.
Formicola D; Petrosino G; Lasorsa VA; Pignataro P; Cimmino F; Vetrella S; Longo L; Tonini GP; Oberthuer A; Iolascon A; Fischer M; Capasso M
J Transl Med; 2016 May; 14(1):142. PubMed ID: 27188717
[TBL] [Abstract][Full Text] [Related]
12. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
13. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells.
Holmquist L; Jögi A; Påhlman S
Int J Cancer; 2005 Aug; 116(2):218-25. PubMed ID: 15800931
[TBL] [Abstract][Full Text] [Related]
15. Influence of hypoxia-dependent factors on the progression of neuroblastoma.
Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
Pediatr Surg Int; 2016 Feb; 32(2):187-92. PubMed ID: 26510737
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.
Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L
PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer.
Fjeldbo CS; Julin CH; Lando M; Forsberg MF; Aarnes EK; Alsner J; Kristensen GB; Malinen E; Lyng H
Clin Cancer Res; 2016 Aug; 22(16):4067-76. PubMed ID: 27012812
[TBL] [Abstract][Full Text] [Related]
18. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
19. Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.
Fardin P; Cornero A; Barla A; Mosci S; Acquaviva M; Rosasco L; Gambini C; Verri A; Varesio L
J Biomed Biotechnol; 2010; 2010():878709. PubMed ID: 20652058
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
